About Rivastigmine Hydrogen Tartrate
            
            Class: | Cholinesterase inhibitor  
Use: | Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease dementia  
Adult dose: | Initial dose of 1.5 mg taken twice daily; may be increased to 3 mg twice daily after a minimum of 4 weeks based on tolerability and efficacy; maximum dose is 6 mg twice daily  
Pediatric dose: | Not established; not recommended for pediatric use  
Side effects: | Nausea, vomiting, diarrhea, loss of appetite, weight loss, abdominal 
         
        
            
                
                
                    
                        Drug Class
                    
                    Cholinesterase inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease dementia
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from moisture; keep out of reach of children
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: TAHA PHARMA, TUNISIA
                    
                    
                    Package Size
                    30s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 109.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 1.5 mg taken twice daily; may be increased to 3 mg twice daily after a minimum of 4 weeks based on tolerability and efficacy; maximum dose is 6 mg twice daily
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; not recommended for pediatric use
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, loss of appetite, weight loss, abdominal pain, fatigue, dizziness, tremors
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to rivastigmine or any component of the formulation; history of severe skin reactions (e.g., Stevens-Johnson syndrome)
         
        
        
            
                Important Warnings
            
            May cause bradycardia; monitor heart rate; use caution in patients with a history of gastrointestinal ulcers or seizures; may exacerbate conditions such as asthma or COPD; not recommended for use in patients with severe hepatic impairment
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.